Replies to post #11374 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Yes, indeed. He was in rare form, so overconfident. Wow, 45 business days or less, the FDA will give us the answer if it’s a go or not. With the p3 trial data producing a p-value of -.001, how could the FDA say no to it. It not only benefits the patients but the overall cost of treatiing LN. Greenleaf is not in favor of partnering the drug with big pharma. He said they will commercialize it but will have open ears if other parties express interest on it.

[slimhere]

AUPH's option market isn't the norm, check out this:


Bid/Ask
0.47/ 4.65

Those are for the 15's. I've complained to TDAmeritrade about these asinine spreads before when I have gotten margin calls from them, right now I have a 9,650.00 maintenance requirement for 10 contracts and the 13's are even worse. TDA has called the MM and then maybe for a couple of days they have a normal B/A, but not for long. Great work on the SEC part.

IMO, and I have zero idea if I'm right, but I believe today's gain is because the MM do not have the shares to sell, they sold naked puts and now have to deal with having a short book.

As for you being a newbie in options, you have my congratulations on making money on the 12's. I didn't. It's also my opinion that we are done seeing the 13 and are off to the FDA races. Time will tell, GL

Lastly, I'm concerned about these maintenance requirement for I presently can't sell next months. Bastards! Dec 18 options for a strike at 15 is Bid 1.75 Ask 2.15